Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation
Ying Dai(Beth Israel Deaconess Medical Center), David K. Simon(Beth Israel Deaconess Medical Center)
Cited by 94
Related Papers
Meta‐analysis of Parkinson's Disease: Identification of a novel locus, <i>RIT2</i>
|Annals of Neurology|2011|299
Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
|Nature Communications|2023|84
Pgc-1α Overexpression Downregulates Pitx3 and Increases Susceptibility to MPTP Toxicity Associated with Decreased Bdnf
|PLoS ONE|2012|71
Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
|Parkinson s Disease|2011|16